Combined neoadjuvant weekly paclitaxel and trastuzumab for HER2-overexpressing breast cancer

被引：0
|
作者：
Horiguchi, J. [1 ]
Koibuchi, Y. [1 ]
Rokutanda, N. [1 ]
Nagaoka, R. [1 ]
Kikuchi, M. [1 ]
Sato, A. [1 ]
Ishikawa, Y. [1 ]
Odawara, H. [1 ]
Iino, Y. [1 ]
Takeyoshi, I. [1 ]
机构：
[1] Gunma Univ Hosp, Maebashi, Gunma, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3045
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer
    Ewer, Michael S.
    O'Shaughnessy, Joyce A.
    CLINICAL BREAST CANCER, 2007, 7 (08) : 600 - 607
  • [32] Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing metastatic breast cancer
    Burstein, HJ
    Kuter, I
    Campos, SM
    Gelman, RS
    Tribou, L
    Parker, LM
    Manola, J
    Younger, J
    Matulonis, U
    Bunnell, CA
    Partridge, AH
    Richardson, PG
    Clarke, K
    Shulman, LN
    Winer, EP
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2722 - 2730
  • [33] Role of HSP27 in trastuzumab resistance in HER2-overexpressing breast cancer
    Hwang, S-Y.
    Choi, S-K.
    Na, Y.
    Lee, Y-S.
    Kwon, Y.
    ANNALS OF ONCOLOGY, 2017, 28 : 24 - 24
  • [34] Weekly paclitaxel, pertuzumab and trastuzumab (TPH) neoadjuvant therapy for HER2 positive inflammatory breast cancer
    Overmoyer, Beth
    Regan, Meredith
    Hu, Jiani
    Nakhlis, Faina
    Dominici, Laura
    Lin, Nancy U.
    Freedman, Rachel
    Morganstern, Daniel E.
    Partridge, Ann H.
    Schlosnagle, Emily J.
    Hirshfield-Bartek, Judi
    Bellon, Jennifer
    Morikawa, Aki
    Harrison, Beth T.
    Winer, Eric
    CANCER RESEARCH, 2018, 78 (04)
  • [35] Trastuzumab-targeted gene delivery to Her2-overexpressing breast cancer cells
    Mann, K.
    Kullberg, M.
    CANCER GENE THERAPY, 2016, 23 (07) : 221 - 228
  • [36] Predictors of Locoregional Outcome in HER2-Overexpressing Breast Cancer Treated With Neoadjuvant Chemotherapy
    Arsenault, Daniel
    Hurley, Judith
    Takita, Cristiane
    Reis, Isildinha M.
    Zhao, Wei
    Rodgers, Steven
    Wright, Jean L.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2015, 38 (04): : 348 - 352
  • [37] Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer
    Bergen, Elisabeth
    Berghoff, Anna S.
    Rudas, Margaretha
    Dubsky, Peter
    De Vries, Catharina
    Sattlberger, Claudia
    Mader, Robert M.
    Zagouri, Flora
    Sparber, Cornelia
    Fitzal, Florian
    Gnant, Michael
    Rottenfusser, Andrea
    Zielinski, Christoph C.
    Preusser, Matthias
    Steger, Guenther G.
    Bartsch, Rupert
    BREAST CARE, 2014, 9 (05) : 344 - 348
  • [38] Application of intrathecal trastuzumab for treatment of meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer
    Shojima, K.
    Suzuki, E.
    Saito, K.
    Sekine, S.
    Kitagawa, D.
    Aruga, T.
    Saji, S.
    Kuroi, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [39] Influence of trastuzumab on the incidence of brain metastasis in patients with Her2-overexpressing metastatic breast cancer
    Massard, C.
    Brain, E.
    Dunan, A.
    Mathieu, M.
    Guinebretiere, J.
    Abuin, G. Gomez
    Floiras, J.
    Spielmann, M.
    Delaloge, S.
    Andre, F.
    EJC SUPPLEMENTS, 2005, 3 (02): : 119 - 120
  • [40] Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2-Overexpressing Metastatic Breast Cancer
    Huang, Yuan
    Fu, Peifen
    Fan, Weimin
    CURRENT DRUG TARGETS, 2013, 14 (08) : 889 - 898
12345